Equillium Stock Profile

<div class='circular--portrait' style='background:#0D52D1;color: white;font-size:4em;padding-top: 25px;;'>EQ</div>


7 / 100

Odds of Distress

Analyze Filter   Earning Report: March 25, 2020
Equity ratings for Equillium are calculated based on Macroaxis scoring framework. The performance scores are derived for the period starting November 30, 2019 and ending today February 28, 2020. Click here to learn more.

Equillium Profile

Upcoming quarterly earning report is expected on March 25, 2020. Equillium, Inc., a biotechnology company, develops products for autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. Equillium, Inc. was founded in 2017 and is headquartered in San Diego, California. Equillium operates under Biotechnology classification in USA and is traded on BATS Exchange. It employs 16 people. more on Equillium
Equillium Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
Equillium SEC Filings
Equillium SEC Filings
Security & Exchange Commission EDGAR ReportsView All
Legal NameEquillium
President CEO, DirectorGeoffrey RotsteinView All
Thematic Classification
Currently Active Investing Idea
  Pharmaceutical Products
View All
Average Analyst Recommendation
Current trade recommendation based on an ongoing consensus estimate among financial analysis covering Equillium
Piotroski F Score
Academic score to determine the current strength of Equillium financial position
Macroaxis Advice
Macroaxis buy hold or sell recommendation provided in the context of your current investment horizon and risk tolerance.
Horizon: 30 days (very short)Advice
Few selected profitability drivers of Equillium representing accounts that assess its ability to generate profits relative to its revenue, operating costs, and shareholders' equity
Consolidated Income
Net Income
Net Income Common Stock
Operating Income
Equillium (EQ) is traded on BATS Exchange in USA. It is located in 2223 Avenida De La Playa and employs 16 people. Equillium is listed under Pharmaceutical Products category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with market capitalization of 79.41 M. Equillium is active under Healthcare sector as part of Biotechnology industry. The entity has 17.38 M outstanding shares of which 90.11 K shares are currently sold short in the market by investors with about 2.43 days to cover all shorted shares. EMBARQ CORP reports about 62.24 M in cash with (17.74 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.58.
Check Equillium Probability Of Bankruptcy

Ownership Allocation (%)

Equillium Stock Price Odds Analysis

Odds Down 4.62HorizonTargetOdds Up 4.62
53.97%30 days 4.62 45.89%
Based on normal probability distribution, the odds of Equillium to move above current price in 30 days from now is about 45.89 (This Equillium probability density function shows the probability of Equillium Stock to fall within a particular range of prices over 30 days) .

Equillium Stock Top Holders

Equillium Stock Institutional Holders

InstituionSecurity TypeTotal SharesValue
Victory Capital Management IncCommon Shares2.2 M7.5 M
Fmr LlcCommon Shares619.8 K2.1 M
View Equillium Diagnostics

Equillium Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Equillium Stock Against Markets

Did you try this?

Run Commodity Channel Index Now


Commodity Channel Index

Use Commodity Channel Index to analyze current equity momentum
All  Next Launch Module

Equillium Upcoming and Recent Events

Equillium Company Earnings Announcements Dates

Upcoming Quarterly Earning ReportMarch 25, 2020
Next Earnings ReportMay 11, 2020
Next Fiscal Quarter EndDecember 31, 2019
Next Fiscal Year EndMarch 25, 2020
Last Quarter Report DateSeptember 30, 2019
Last Earning Anouncement DateDecember 31, 2018

Equillium Corporate Filings

Equillium SEC Reporting

Unclassified Corporate Event
Financial Statements and Exhibits. Other Events. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Entry into a Material Definitive Agreement
Other Events
Submission of Matters to a Vote of Security Holders

Equillium Corporate Directors

John Fisher Independent Director
Anthony Tjan Independent Director
Marc Lavine Independent Director
Continue to Investing Opportunities. Please also try Stock Screener module to find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Company logos by clearbit